Evoqua Water Technologies Acquires STERIS’ Renal Business
Evoqua Water Technologies Corp. (NYSE:AQUA) made an announcement, according to which it has entered into an agreement to acquire the assets of STERIS’ renal business operated by Mar Cor Purification and Cantel Medical for $196.3 million. The business is estimated to generate around $180 million in annual sales and adjusted EBITDA of around $27 million.
Analysts at Berenberg Bank estimate the deal to add around 8% and 4% to the company’s 2022 and 2023 total sales, respectively. Once integrated, the analysts expect the company to grow its sales at a double-digit rate over the next two years making it one of the fastest-growing companies in the water technology sector.
Overall, Berenberg Bank thinks this is an excellent bolt-on deal for Evoqua Water Technologies, which adds meaningfully to the company’s financials at a very accretive valuation.
| Symbol | Price | %chg |
|---|---|---|
| 6370.T | 5592 | -1.07 |
| 383310.KQ | 24750 | 0.81 |
| 6368.T | 9230 | 0.33 |
| 7004.T | 990 | -0.81 |
Evoqua Water Technologies Acquires STERIS’ Renal Business
Evoqua Water Technologies Corp. (NYSE:AQUA) made an announcement, according to which it has entered into an agreement to acquire the assets of STERIS’ renal business operated by Mar Cor Purification and Cantel Medical for $196.3 million. The business is estimated to generate around $180 million in annual sales and adjusted EBITDA of around $27 million.
Analysts at Berenberg Bank estimate the deal to add around 8% and 4% to the company’s 2022 and 2023 total sales, respectively. Once integrated, the analysts expect the company to grow its sales at a double-digit rate over the next two years making it one of the fastest-growing companies in the water technology sector.
Overall, Berenberg Bank thinks this is an excellent bolt-on deal for Evoqua Water Technologies, which adds meaningfully to the company’s financials at a very accretive valuation.
Evoqua Water Technologies Shares Up 9% Following Q4 Results
Evoqua Water Technologies Corp. (NYSE:AQUA) shares closed 9% higher yesterday, following the company’s Q4 results that beat the consensus estimates and generally in-line 2022 guidance.
The company reiterated confidence in the secular growth opportunities afforded by the intensifying challenges related to water quality/availability. Notably, Q4 book-to-bill remained strong and ISS backlog was stable sequentially (+17% year-over-year, establishing firm momentum into FY22).
Alongside its print, the company also announced new sustainability goals. The team is targeting recycling/reusage of water to exceed withdrawals by 2035 and net-zero greenhouse gas emissions by 2050.
Evoqua Water Technologies Shares Up 9% Following Q4 Results
Evoqua Water Technologies Corp. (NYSE:AQUA) shares closed 9% higher yesterday, following the company’s Q4 results that beat the consensus estimates and generally in-line 2022 guidance.
The company reiterated confidence in the secular growth opportunities afforded by the intensifying challenges related to water quality/availability. Notably, Q4 book-to-bill remained strong and ISS backlog was stable sequentially (+17% year-over-year, establishing firm momentum into FY22).
Alongside its print, the company also announced new sustainability goals. The team is targeting recycling/reusage of water to exceed withdrawals by 2035 and net-zero greenhouse gas emissions by 2050.
